- li>
- li>
- li>
- li>
- li>
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.10 | 0.04 | 145.42 |
| EPS, GAAP | 0.08 | 0.03 | 0.03 |
| Consensus Estimate | 0.08 | 0.05 | 51.24 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 0.74 | -0.64 | -215.90 |
| EPS, GAAP | 0.29 | -0.70 | -141.38 |
| Consensus Estimate | 0.44 | 0.38 | 16.78 |
| BSX | Industry Average | |
| P/E (TTM) | 16.91 | NA |
| P/E (Forward) | 13.81 | NA |
| PEG Ratio | 2.18 | 1.15 |
| Price/Sales | 1.14 | 1.95 |
| Beta | 1.00 | 0.94 |
| 11:27 AM | 5/22/2012 | 2nd UPDATE: Medtronic 4Q Profit Rose 28% On Fewer Charges |
| 9:07 AM | 5/18/2012 | US STOCK FUTURES: HOT STOCKS TO WATCH |
| 5/23/2012 | Can US Biotechs Inject Life To Australia's IPO Market? (WSJ.com) |
| 5/22/2012 | Medtronic's Earnings Rise (WSJ.com) |
| 5/18/2012 | Stocks to Watch: Facebook, Gap, Salesforce (WSJ.com) |
| 5/18/2012 | Futures Point Higher Ahead of Facebook IPO (Barrons.com) |
| 5/9/2012 | Morgan Stanley Upgrades St. Jude, Stock Rises (Barrons.com) |
| 5/7/2012 | Barron's 500 (Barrons.com) |
| 5/7/2012 | Bravo to the Best! (Barrons.com) |
| 4/26/2012 | FDA Panel Backs New Defibrillator (WSJ.com) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)